News

Adjunctive Telaprevir Boosts Response in Chronic HCV


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Both studies were funded by Tibotec and Vertex Pharmaceuticals, which both manufacture telaprevir. Dr. Zeuzem and Dr. Jacobson reported ties to Tibotec and Vertex, as well as to numerous other industry sources.

Pages

Recommended Reading

Consider Celiac Disease in Autoimmune Disorder Patients
MDedge Family Medicine
Inspection During Colonoscope Insertion Provides No Added Benefit
MDedge Family Medicine
Link Between Proton Pump Inhibitors, Hip Fractures Confirmed
MDedge Family Medicine
Multiple Factors Influence Detection of Colorectal Adenomas
MDedge Family Medicine
Infliximab Increases Post-IPAA Complications in Children
MDedge Family Medicine
Vancomycin Monotherapy Linked to C. Difficile Recurrence in IBD
MDedge Family Medicine
Cyclosporine No Better Than Infliximab for Ulcerative Colitis
MDedge Family Medicine
Continued Aspirin Use Does Not Impede Ulcer Healing
MDedge Family Medicine
Adalimumab Appears Safe for Inducing Remission in Pediatric Crohn's
MDedge Family Medicine
Link Between PPIs and C. difficile Inconsistent
MDedge Family Medicine